Ipragliflozin: all 48 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)CompletedNCT02577003Phase 3Results posted
• Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)CompletedNCT02564211Phase 3Results posted
• A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaTerminatedNCT03118713Phase 4
• Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and MetforminCompletedNCT03076112Phase 3
• A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes MellitusCompletedNCT02897219Phase 3
• Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and PioglitazoneCompletedNCT02875821Phase 4
• Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin TherapyCompletedNCT02847091Phase 4
• Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes MellitusCompletedNCT02529449Phase 2
• A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and SitagliptinCompletedNCT02452632Phase 3
• Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02291874Phase 4
• A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT02175784Phase 4
• A Study to Compare the Oral Absorption of ASP1941 Among Two Types of TabletsCompletedNCT01972880Phase 1
• Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy AdultsCompletedNCT01678287Phase 1
• A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941CompletedNCT01674777Phase 1
• A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes PatientsCompletedNCT01672762Phase 3
• Absolute Bioavailability Study With IpragliflozinCompletedNCT01611428Phase 1
• Drug to Drug Interaction Study With Ipragliflozin and FurosemideCompletedNCT01611415Phase 1
• A Phase 1 Study to Investigate the Mechanism of Action of IpragliflozinCompletedNCT01611363Phase 1
• A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusTerminatedNCT01514838Phase 3
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsCompletedNCT01505426Phase 3
• A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma ConcentrationCompletedNCT01403818Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese SubjectsCompletedNCT01373060Phase 1
• A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic PatientsCompletedNCT01316107Phase 3
• A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal ImpairmentCompletedNCT01316094Phase 3
• Drug-drug Interaction Study With ASP1941 and GlimepirideCompletedNCT01302158Phase 1
• Drug to Drug Interaction Study With ASP1941 and MetforminCompletedNCT01302145Phase 1
• Mass Balance Study of ASP1941CompletedNCT01302132Phase 1
• Renal Impairment Study With ASP1941CompletedNCT01302028Phase 1
• Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941CompletedNCT01288898Phase 1
• First in Men Study of Single Oral Doses of ASP1941 in Healthy SubjectsCompletedNCT01288885Phase 1
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsCompletedNCT01242228Phase 3
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic PatientsCompletedNCT01242202Phase 3
• A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy SubjectsCompletedNCT01232413Phase 1
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic PatientsCompletedNCT01225081Phase 3
• A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941CompletedNCT01187186Phase 1
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic PatientsCompletedNCT01135433Phase 3
• A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy SubjectsCompletedNCT01121198Phase 1
• A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes MellitusCompletedNCT01117584Phase 2
• A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy SubjectsCompletedNCT01104532Phase 1
• A Study to Assess Drug-Drug Interaction Between ASP1941 and MiglitolCompletedNCT01099839Phase 1
• A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal ImpairmentCompletedNCT01097681Phase 1
• A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy SubjectsCompletedNCT01088919Phase 1
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes MellitusCompletedNCT01071850Phase 2
• A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes PatientsCompletedNCT01057628Phase 3
• A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic PatientsCompletedNCT01054092Phase 3
• A Study of ASP1941 in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01023945Phase 1
• A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.CompletedNCT00790660Phase 2
• A Study of ASP1941 in Participants With Type 2 Diabetes MellitusCompletedNCT00621868Phase 2

← Ipragliflozin overview